baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

AIRWAY/ PLAIRWY00017 /

2024-04-26 5:00:00 PM	Chg. +0.01	Volume	Bid9:10:00 PM	Ask9:10:00 PM	High	Low
0.29PLN	+3.80%	630,115 Turnover: 176,085.36	-Bid Size: -	-Ask Size: -	0.29	0.27

GlobeNewswire 04-24 ASLAN Pharmaceuticals Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentat...

GlobeNewswire 04-16 Incannex Healthcare Inc. Quarterly Update, Q1 2024

GlobeNewswire 04-12 ASLAN Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corpo...

GlobeNewswire 04-11 Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Rese...

GlobeNewswire 04-09 Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursem...

GlobeNewswire 04-03 Apnimed to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire 03-28 Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operatio...

GlobeNewswire 03-28 4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cy...

GlobeNewswire 03-28 Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conf...

GlobeNewswire 03-25 Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

GlobeNewswire 03-13 Protara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Busi...

GlobeNewswire 03-12 MediciNova Announces New Data and Results of MN-166 (ibudilast) in Chlorine Gas-induced Acute Lung I...

GlobeNewswire 03-06 Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference

GlobeNewswire 03-06 ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading R...

GlobeNewswire 03-04 REMSleep Holdings Shareholder Update

GlobeNewswire 02-23 Jasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Al...

GlobeNewswire 02-22 Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference

GlobeNewswire 02-20 Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introd...

GlobeNewswire 02-15 Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross Pro...

GlobeNewswire 02-12 ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions abo...

GlobeNewswire 02-12 Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

GlobeNewswire 02-06 Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth...

GlobeNewswire 02-05 Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Nex...

GlobeNewswire 01-30 ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA

GlobeNewswire 01-23 4DMT Receives Rare Pediatric Disease Designation from FDA for Aerosolized 4D-710 for Treatment of Cy...

AIRWAY/ PLAIRWY00017 /

If you wish to receive reply to your feedback, please provide your email address.